Federated Hermes Inc. Increases Position in Teladoc Health, Inc. (NYSE:TDOC)

Federated Hermes Inc. increased its stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 18.1% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 398,791 shares of the health services provider's stock after purchasing an additional 61,194 shares during the quarter. Federated Hermes Inc. owned approximately 0.23% of Teladoc Health worth $3,174,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in shares of Teladoc Health by 5.9% during the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider's stock worth $167,830,000 after purchasing an additional 1,029,829 shares in the last quarter. Point72 Asset Management L.P. increased its position in Teladoc Health by 33.6% during the 4th quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock valued at $101,625,000 after buying an additional 2,813,568 shares in the last quarter. Renaissance Technologies LLC raised its stake in Teladoc Health by 15.5% in the fourth quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider's stock valued at $51,582,000 after buying an additional 763,265 shares during the last quarter. Geode Capital Management LLC raised its stake in Teladoc Health by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock valued at $35,894,000 after buying an additional 22,664 shares during the last quarter. Finally, Maple Rock Capital Partners Inc. boosted its holdings in Teladoc Health by 189.5% in the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock worth $32,369,000 after acquiring an additional 2,331,000 shares in the last quarter. Institutional investors own 76.82% of the company's stock.

Insider Activity at Teladoc Health

In related news, insider Adam C. Vandervoort sold 5,808 shares of Teladoc Health stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $39,842.88. Following the sale, the insider directly owned 69,773 shares in the company, valued at approximately $478,642.78. The trade was a 7.68% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Carlos Nueno sold 3,958 shares of the stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total value of $27,151.88. Following the transaction, the insider directly owned 17,645 shares of the company's stock, valued at $121,044.70. The trade was a 18.32% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 18,656 shares of company stock valued at $128,189. 0.58% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

TDOC has been the topic of several recent analyst reports. The Goldman Sachs Group cut their price objective on shares of Teladoc Health from $13.00 to $10.00 and set a "buy" rating on the stock in a report on Thursday, May 1st. Jefferies Financial Group decreased their price target on shares of Teladoc Health from $10.00 to $8.00 and set a "hold" rating for the company in a report on Monday, April 21st. Mizuho assumed coverage on shares of Teladoc Health in a report on Friday, July 25th. They set a "neutral" rating and a $10.00 price objective on the stock. Canaccord Genuity Group reduced their target price on Teladoc Health from $14.00 to $12.00 and set a "buy" rating for the company in a research note on Thursday, May 1st. Finally, Bank of America lowered their price target on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a research report on Wednesday, May 28th. Twelve research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $9.76.

Teladoc Health Stock Performance

TDOC stock traded up $0.03 during midday trading on Friday, hitting $6.98. 3,214,152 shares of the stock traded hands, compared to its average volume of 7,024,993. The stock's fifty day simple moving average is $7.71 and its 200-day simple moving average is $8.44. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.67 and a quick ratio of 2.58. Teladoc Health, Inc. has a 1-year low of $6.35 and a 1-year high of $15.21. The firm has a market cap of $1.23 billion, a P/E ratio of -5.86 and a beta of 1.76.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.27) by $0.08. The firm had revenue of $631.90 million for the quarter, compared to analyst estimates of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%. The business's revenue was down 1.6% on a year-over-year basis. During the same quarter last year, the firm posted ($0.38) EPS. On average, analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.